Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 27 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

19%

5 trials in Phase 3/4

Results Transparency

8%

1 of 12 completed trials have results

Key Signals

6 recruiting1 with results

Enrollment Performance

Analytics

N/A
8(53.3%)
Phase 4
4(26.7%)
Phase 2
2(13.3%)
Phase 3
1(6.7%)
15Total
N/A(8)
Phase 4(4)
Phase 2(2)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (27)

Showing 20 of 27 trials
NCT07497867Recruiting

Long-term Prospective Study of Korean CADASIL Patients

Role: collaborator

NCT07452666Not ApplicableNot Yet Recruiting

FISTULA-RFA Trial: Radiofrequency Ablation for Perianal Fistula

Role: lead

NCT07437573Phase 3Completed

Oncometabolic Surgery

Role: collaborator

NCT05221931Not ApplicableActive Not Recruiting

Drug-Coated Balloon in Patients With High Bleeding Risk

Role: collaborator

NCT06874894Enrolling By Invitation

Thromboembolic And Bleeding Risks During anticoaGulant trEatment in Asian paTients With Atrial Fibrillation (TARGET-AF)

Role: collaborator

NCT04010955Active Not Recruiting

Adding Antiplatelet During Edoxaban Treatment in Stroke Patients With Non-valvular Atrial Fibrillation (ADD-ON)

Role: collaborator

NCT05148286Phase 4Recruiting

Albumin and Crystalloid Administration in Septic Shock

Role: collaborator

NCT05400785Not ApplicableCompleted

Efficacy of the Mobile Application for Prediction and Prevention of Mood Episode Recurrence Based on Machine Learning

Role: collaborator

NCT06779695Active Not Recruiting

Prediction of Systemic Thromboembolism and Bleeding in Atrial Fibrillation Patients With Factor Xa Inhibitor (Apixaban, Rivaroxaban) by Echocardiographic Parameters: Prospective Observational Study (AF-ECHO Study)

Role: collaborator

NCT02619994Phase 2Completed

Treatment Shortening of MDR-TB Using Existing and New Drugs

Role: collaborator

NCT04691674Not ApplicableCompleted

Optimal Placement Duration of Pancreatic Duct Stent

Role: collaborator

NCT05438121Recruiting

STabilization of Atheroma by Lipid-reducing Effect of Drug-Coated Balloon (STABLE-DCB)

Role: lead

NCT03993236Phase 4Completed

Study on Rosuvastatin+Ezetimibe and Rosuvastatin for LDL-C Goal in Patients With Recent Ischemic Stroke

Role: collaborator

NCT06454149Recruiting

Cohort Study for Gastric MALT Lymphoma

Role: collaborator

NCT06290271Recruiting

Arterial Wall Shear Stress After Intracranial Artery Recanalization

Role: collaborator

NCT06191926Completed

Diagnostic Performance of Shear Wave Dispersive Imaging in Breast Lesions: Comparison With Shear Wave Elastography

Role: lead

NCT06104189Completed

Prospective Ultrafast MRI Radiomics for Breast Cancer

Role: lead

NCT06095414Completed

Prospective Radiomics Study for Breast Cancer

Role: lead

NCT05978154Unknown

Thigh Muscle Mass and Muscle Wasting in Patients in the Emergency Department

Role: lead

NCT04284943Not ApplicableUnknown

Surgical TreAtment for Obesity Related Disease and Onco-Metabolic Surgery

Role: collaborator